Abstract
New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Current Proteomics
Title: New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis
Volume: 1 Issue: 1
Author(s): Corinne Stannard, Larry R. Brown and Jasminka Godovac-Zimmermann
Affiliation:
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Abstract: New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Export Options
About this article
Cite this article as:
Stannard Corinne, Brown R. Larry and Godovac-Zimmermann Jasminka, New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis, Current Proteomics 2004; 1 (1) . https://dx.doi.org/10.2174/1570164043488243
DOI https://dx.doi.org/10.2174/1570164043488243 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Segmentation and Classification of Lung Cancer: A Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Herpes Simplex Viruses in Antiviral Drug Discovery
Current Pharmaceutical Design Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
Current Medicinal Chemistry Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets Meet the Guest Editor
Current Genomics Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition Pharmacologic Ovarian Preservation in Young Women Undergoing Chemotherapy
Current Medicinal Chemistry Increasing Sensitivity to Radiotherapy and Chemotherapy by Using Novel Biological Agents that Alter the Tumor Microenvironment
Current Molecular Medicine Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Current Stem Cell Research & Therapy Effects and Role of Multikinase Inhibitors in Thyroid Cancer
Current Pharmaceutical Design Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Recent Advance in the Research of Flavonoids as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Adrenomedullin-RAMP2 System in Cardiovascular Development and Homeostasis
Current Hypertension Reviews Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications
Current Pharmaceutical Design Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Reversal of Bone Cancer Pain by HSV-1-Mediated Silencing of CNTF in an Afferent Area of the Spinal Cord Associated with AKT-ERK Signal Inhibition
Current Gene Therapy